Uterine sarcoma: 14 years experience in KCCC
Affiliations
Affiliations
- Radiation Oncology Department, Kuwait Cancer Control Centre. hesham_elewekel@yahoo.com
Abstract
Aim of the work: To asses the profile, pattern of failure and survival for patients with uterine sarcoma seen in KCCC.
Material and methods: A total of 23 records for patients with uterine sarcoma attending KCCC between July 1993 to May 2007 were available for review. The medical records were assessed for the profile of the disease, histological types, types of treatment, pattern of failure and survival. All cases were proven histologically. The majority of cases 15/23 (65.2%) were endometrial stromal sarcoma, 4/23 (17.4%) had leiomyosarcoma and 4/23 (17.4%) had carcinosarcoma. Twenty two out of 23 patients (95.6%) had surgery and 8/22 (36.4%) were given adjuvant post-operative pelvic radiotherapy. Three patients were treated with palliative intent by radiation. Five patients received palliative chemotherapy.
Results: The mean age of all patients was 53.17+/-11.06 (range 34-80 years). The majority of patients 15/23 (65.2%) had stage I disease. High tumor grade was seen in 12/23 (52.2%) of patients. The pattern of failure was local in only 2 patients, systemic in 4 patients and both local and systemic in 5 patients. The overall DFS-5 years was 59.6%.The 5 y-DFS for patients treated by surgery & RT was 87.5% compared to 36.4% for those treated by surgery alone. Patients with early disease (stage I) had a 5 year DFS of 74% compared to 33.3% for those with advanced disease (stages III&IV). Patients with high grade tumors had a 5 year- DFS of 27% versus 100% for those with low grade tumors.
Conclusion: Stage and grade are important predictors of survival. Post-operative adjuvant pelvic irradiation is associated with improved 5-years DFS.
Similar articles
[Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F, Terzibachian JJ, Aouar Z, Govyadovskiy A, Lassabe C.Gynecol Obstet Fertil. 2008 Jun;36(6):628-35. doi: 10.1016/j.gyobfe.2008.03.012. Epub 2008 Jun 5.PMID: 18538624 French.
Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
Ghaemmaghami F, Karimi-Zarchi M, Gilani MM, Mousavi A, Behtash N, Ghasemi M.Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):421-6.PMID: 18990014
Uterine sarcoma-current management and experience from a regional cancer centre in North India.
Biswas A, Patel F, Kumar P, Srinivasan R, Bera A, Sharma SC, Rajwanshi A.Arch Gynecol Obstet. 2013 Oct;288(4):873-82. doi: 10.1007/s00404-013-2843-7. Epub 2013 Apr 12.PMID: 23580012
Coquard R, Romestaing P, Ardiet JM, Mornex F, Sentenac I, GĂ©rard JP.Bull Cancer. 1997 Jun;84(6):625-9.PMID: 9295866 Review. French.
The management of patients with uterine sarcoma: a debated clinical challenge.
Gadducci A, Cosio S, Romanini A, Genazzani AR.Crit Rev Oncol Hematol. 2008 Feb;65(2):129-42. doi: 10.1016/j.critrevonc.2007.06.011. Epub 2007 Aug 13.PMID: 17706430 Review.
References
https://pubmed.ncbi.nlm.nih.gov/